Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $287.9b | $188.18 | +1.5% | 2.5M |
 TMO | Thermo Fisher Scientific, Inc. | $183.0b | $509.73 | +1.4% | 2.9M |
 DHR | Danaher Corporation | $129.3b | $195.13 | +1.5% | 3.3M |
 WAT | Waters Corp | $37.7b | $374.51 | -0.7% | 795.5K |
 GH | Guardant Health, Inc. Common Stock | $17.2b | $150.70 | +4.5% | 3.7M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.0b | $70.87 | +0.9% | 5.3M |
 RVTY | Revvity, Inc. | $11.7b | $113.03 | -0.4% | 2.4M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $9.8b | $329.69 | -0.0% | 965.6K |
 TEM | Tempus AI, Inc. Class A Common Stock | $9.1b | $55.90 | +2.2% | 7.9M |
 NUVL | Nuvalent, Inc. Class A Common Stock | $8.7b | $123.85 | -0.0% | 1.6M |
 TECH | Bio-Techne Corp. | $8.1b | $70.42 | +0.4% | 10.2M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.7b | $108.20 | -7.5% | 2.1M |
 LNTH | Lantheus Holdings, Inc | $6.5b | $109.25 | +0.6% | 899.0K |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.7b | $18.71 | -1.0% | 4.0M |
 TWST | Twist Bioscience Corporation Common Stock | $4.2b | $98.00 | +3.3% | 2.7M |
 DYN | Dyne Therapeutics, Inc. Common Stock | $3.2b | $20.93 | +1.8% | 2.7M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $2.6b | $35.44 | +1.2% | 1.7M |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $2.4b | $21.02 | +3.4% | 2.7M |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.5b | $69.35 | +1.7% | 944.1K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $29.22 | +5.3% | 1.6M |
 CDNA | CareDx, Inc. | $1.2b | $28.96 | +3.3% | 684.5K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.8b | $7.00 | +1.6% | 479.1K |
 ANRO | Alto Neuroscience Inc. | $0.7b | $26.93 | +6.9% | 493.6K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.6b | $24.25 | +5.9% | 389.0K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.5b | $4.58 | -0.2% | 1.0M |
 LAB | Standard BioTools Inc. Common Stock | $448.9m | $0.77 | +1.6% | 4.0M |
 OABI | OmniAb, Inc. Common Stock | $391.4m | $2.49 | 0.0% | 496.4K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $362.5m | $5.76 | +1.4% | 413.2K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $348.2m | $2.09 | -9.0% | 2.5M |
 PRLD | Prelude Therapeutics Incorporated | $312.2m | $4.22 | +6.7% | 408.2K |
 AVXL | Anavex Life Sciences | $280.8m | $2.60 | +5.9% | 1.2M |
 ACIU | AC Immune SA | $270.7m | $2.56 | +4.3% | 233.2K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $259.1m | $0.86 | -0.8% | 3.9M |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $258.6m | $27.21 | -2.5% | 830.6K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $251.3m | $4.21 | +4.7% | 292.0K |
 BDSX | Biodesix, Inc. Common Stock | $169.0m | $22.89 | +11.7% | 129.3K |
 QTRX | Quanterix Corporation Common Stock | $144.1m | $4.28 | +14.6% | 2.1M |
 XGN | Exagen Inc. Common Stock | $120.3m | $4.59 | -1.0% | 328.0K |
 SEER | Seer, Inc. Class A Common Stock | $102.8m | $1.67 | -3.5% | 320.7K |
 IBIO | iBio, Inc. Common Stock | $94.4m | $1.66 | +4.4% | 1.4M |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $84.6m | $1.79 | -1.4% | 24.0K |
 CSBR | Champions Oncology, Inc. | $81.0m | $6.51 | 0.0% | 8.7K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $68.5m | $1.63 | +5.7% | 219.3K |
 MDXH | MDxHealth SA Ordinary Shares | $39.0m | $0.44 | -2.3% | 1.1M |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $33.1m | $7.42 | -4.5% | 12.5K |
 CCEL | Cryo-Cell International Inc. | $27.1m | $2.98 | -24.5% | 12.4K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $26.1m | $1.31 | +1.6% | 118.7K |
 ADVB | Advanced Biomed Inc. Common Stock | $8.2m | $4.50 | -7.5% | 3.3K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.6m | $2.00 | 0.0% | 23.5K |